Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621)
10/2002
10/23/2002CN1376150A Drug compositions exhibiting thrombo poietin agonism
10/23/2002CN1093124C Substituted 4-hydroxy-phenylalcanoic acid derivatives with agonist activity to PPAR-gamma
10/23/2002CN1093123C Aralkyl and aralkylidene heterocyclic lactams and imides
10/23/2002CN1092960C Pharmaceutical composition comprising proteinase inhibitor and monoglyceride
10/22/2002US6469167 Improved process for the preparation of 5-(4-((3-methyl-4-oxo-3,4-dihydroquinazolin-2-yl)methoxy)benzyl) thiazolidine-2,4-dione
10/22/2002US6469047 Tyrosine derivatives
10/22/2002US6469039 Benzimidazoles; thrombin- inhibiting activity and the effect of extending thrombin time
10/22/2002US6469038 Heteroaryl alkyl alpha substituted peptidylamine calcium channel blockers
10/22/2002US6469036 Peptidyl heterocyclic ketones useful as tryptase inhibitors
10/22/2002US6469028 Synthesis and use of retinoid compounds having negative hormone and/or anatgonist activities
10/22/2002US6469004 Benzoheterocycles and their uses as MEK inhibitors
10/22/2002US6469000 1,3-diheterocyclic metalloprotease inhibitors
10/17/2002WO2002081435A1 Sulphones which modulate the action of gamma secretase
10/17/2002WO2002081429A1 Novel compound having oxime group and insecticide/acaricide
10/17/2002WO2002081428A1 Benzene compound and salt thereof
10/17/2002WO2002081426A1 Peptide deformylase inhibitors
10/17/2002WO2002062301A3 Method and composition for rejuvinating cells, tissues, organs, hair and nails
10/17/2002WO2002059114A9 Lfa-1 antagonist compounds
10/17/2002WO2002057261A3 Diaminothiazoles and their use as inhibitors of cyclin-dependent kinase
10/17/2002WO2002049626A3 The use of ppar-gamma agonists for treating diseases characterised by neuron degeneration, neuron injury or impaired pasticity
10/17/2002WO2002044156A3 Benzimidazole derivatives useful as tie-2 and/or vegfr-2 inhibitors
10/17/2002US20020151720 Naphthol derivatives
10/17/2002US20020151569 Peroxisome Proliferator Activated Receptors (PPARs) antagonists 4-oxo-5-thiazolidine acetamide derivatives
10/17/2002US20020151566 Phosphodiesterase 4 inhibitors
10/17/2002US20020151554 Cyclin-dependent kinase inhibitors such as (4-Amino-2-((4-(4-methyl-1-piperazinyl)phenyl)amino)-5-thiazolyl) (2,3-dihydro-1,4-benzodioxin-6-yl)methanone for treatment of breast, lung, colon, and prostate cancer/tumors
10/17/2002US20020151531 Administering to a female of child bearing age over a period of 28 consecutive days a first phase of from 18 to 21 daily dosage units of a progestational agent, and a second phase of from 1 to 7 daily dosage units of an antiprogestin agent
10/17/2002DE10118310A1 New 2-azolyl-cycloalkane-1,3-dione derivatives, useful as pesticides, e.g. fungicides, herbicides, insecticides, acaricides, nematocides, ectoparasiticides and antifouling agents
10/17/2002DE10114970A1 New 1,2-diamino-4-azolyl-, -4-furyl-, -4-thienyl-, -4-phenyl- and -4-azinyl-benzene compounds and known analogues are used in oxidative colorants for keratin fibers, especially human hair
10/16/2002EP1249233A1 Npyy5 antagonists
10/16/2002EP1248615A1 Thiazole, imidazole and oxazole compounds and treatments of disorders associated with protein aging
10/16/2002EP1248612A1 Novel compounds and compositions as protease inhibitors
10/16/2002EP0934316B1 Azabicyclic carbamoyloxy mutilin derivatives for antibacterial use
10/16/2002EP0831826B1 Pharmaceutical composition comprising a proteinase inhibitor and a monoglyceride
10/16/2002EP0813542B1 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
10/16/2002EP0542136B1 1-[(1,4-benzodioxanyl)alkyl]-4-(heteroaryl) piperidines, piperazines and pyrrolidines as antipsychotic agents
10/16/2002CN1374955A Oxa-and thiazole derivatives useful as antidiabetic and antibesity agents
10/16/2002CN1374864A Prevention and therapeutic agents for cancer
10/16/2002CN1092649C Thiazolidinone compounds or angina pectoris curing or preventing agent with the same as active ingredient
10/15/2002US6465663 Ethyl (e)-4-(2-(5,6-dihydro-5,5-dimethyl-naphthalen-8(7h)-one-2 -yl)ethenyl)benzoate and ethyl (e)-4-(2-(5,6-dihydro-5,5-dimethyl-8-(phenylthio)-naphthalenyl)ethenyl) benzoate
10/15/2002US6465513 Multicyclic compounds which inhibit leukocyte adhesion mediated by VLA-4
10/15/2002US6465501 Azolidines as β3 adrenergic receptor agonists
10/15/2002US6465497 Arylthiazolidinedione derivatives
10/15/2002US6465474 Treatment of such as osteoarthitis, rheumatoid arthritis, prevention or arrest of tumor growth and metastasis, corneal ulceration, lack of corneal healing, macular degeneration, periodontal disease, gingivitis
10/15/2002US6465457 Carbonate, carbamate, thiocarbonate dithiocarbonate and thiocarbomate derivatives useful as fungicides
10/15/2002CA2253795C Substituted 4-arylbutyric acid derivatives as matrix metalloprotease inhibitors
10/15/2002CA2112690C Amino acid derivative
10/10/2002WO2002080161A2 Optical data carrier that contains a merocyanine dye as the light-absorbing compound in the information layer
10/10/2002WO2002080160A1 Optical data carrier that contains a cationic aminoheterocyclic dye as the light-absorbing compound in the information layer
10/10/2002WO2002080159A1 Optical data carrier that contains a cyanine dye as the light-absorbing compound in the information layer
10/10/2002WO2002079177A1 Process for producing (4-phenylthiazol-2-yl)alkanenitrile
10/10/2002WO2002078693A2 N-(2-arylethyl)benzylamines as antagonists of the 5-ht6 receptor
10/10/2002WO2002078626A2 Therapeutic combinations for cardiovascular and inflammatory indications
10/10/2002WO2002078625A2 Therapeutic combinations for cardiovascular and inflammatory indications
10/10/2002WO2001072685A9 Polyamine analogues as cytotoxic agents
10/10/2002US20020147336 Glucocorticoid receptor modulators
10/10/2002US20020147234 Nitrate esters and methods of making same
10/10/2002US20020147194 Psychological disorders; antiserotonin agents; headache therapy
10/10/2002US20020147182 13-substituted methacycline compounds
10/10/2002DE10117676A1 Pesticidal composition, useful for controlling fleas and ticks on animals, contains permethrin and imidacloprid, in N-methylpyrrolidone
10/10/2002CA2442328A1 Therapeutic combinations for cardiovascular and inflammatory indications
10/09/2002EP1246625A2 Methods and compositions for mitigating pain using nitrate esters
10/09/2002CN1373754A Antibacterial agents
10/09/2002CN1092193C Prolylendopeptidase inhibitors
10/08/2002USRE37873 Phenylacetic acid derivatives, preparation thereof and intermediates therefor, and compositions containing them
10/08/2002US6462092 Such as 3-((3-fluorophenyl)-((3-(trifluoromethyl)phenyl)-methyl)amino)-1,1,1 -trifluoro-2-propanol; cardiovascular disease, i.e. atherosclerosis and other coronary artery diseases
10/08/2002US6462073 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
10/08/2002US6462049 Low toxicity and persistent insecticides and fungicides; preventing attachment of aquatic organisms; ecosystem friendly; nonpolluting
10/08/2002US6462043 Method for producing substituted-2-nitroguanidine derivatives
10/08/2002CA2250243C Thiazoline acid derivatives
10/03/2002WO2002076964A1 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same
10/03/2002WO2002076963A1 Bicyclic guanidine derivatives and therapeutic uses thereof
10/03/2002WO2002076962A1 Process for producing 3-oxo-2-(2-thiazolyl)propanenitrile and intermediate
10/03/2002WO2002076957A1 Activator for peroxisome proliferator-activated receptor
10/03/2002WO2002076926A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc chemokine receptor antagonists
10/03/2002WO2002076450A1 Dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
10/03/2002WO2002076177A2 Design and synthesis of optimized ligands for ppar
10/03/2002WO2001020331A9 Substrates and screening methods for transport proteins
10/03/2002US20020143187 Nitric oxide donors and pharmaceutical compositions containing them
10/03/2002US20020143186 For prophylaxis and therapy of hyperglycemia, Type 1 diabetes, Type 2 diabetes, disorders of the lipid metabolism, such as dyslipidemia, and obesity
10/03/2002US20020143182 For therapy of diseases having uncontrolled cellular proliferation
10/03/2002US20020143177 For inhibiting beta-secretase enzyme activity and A beta peptide production, inhibition of beta-secretase enzyme activity halts or reduces production of A beta from APP and reduces or eliminates the formation of beta-amyloid deposits
10/03/2002US20020143034 Aminoalcohol derivatives and their use as beta 3 adrenergic agonists
10/03/2002US20020143020 Novel piperazine derivatives
10/03/2002US20020142969 Using didepsipeptide for the control of endoparasites in medicine and veterinary medicine
10/03/2002US20020142967 Thrombin inhibitors
10/03/2002US20020142290 Compound for use in the treatment of viral diseases
10/03/2002US20020139959 Thiazolidines and use thereof for corrosion inhibition
10/03/2002CA2441092A1 Dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
10/03/2002CA2436351A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc chemokine receptor antagonists
10/02/2002EP1245568A1 Sulfonyl derivatives of amino acids and their use as inhibitors of dipeptidyl-peptidase IV (DPP IV)
10/02/2002EP1244642A1 Substituted oxazoles and thiazoles derivatives as hppar alpha activators
10/02/2002EP1244641A1 Thiazolyl amide derivatives
10/02/2002EP1244621A1 Nitrile derivatives as cathepsin k inhibitors
10/02/2002EP0871465B1 Use of ritonavir (abt-538) for improving the pharmacokinetics of drugs metabolized by cytochrome p450 in a method of treating aids
10/02/2002DE10123210C1 New ether carboxylic acids and salts derived from alkoxylated mercaptobenzothiazoles are used as corrosion inhibitors in metal working and petroleum and natural gas recovery and processing
10/02/2002DE10111936C1 N-Heteroarylmethyl-m-phenylendiamin-Derivate enthaltende Haarfärbemittel sowie neue N-Heteroarylmethyl-m-phenylendiamin-Derivate N-heteroarylmethyl-m-phenylenediamine derivatives, hair dyes containing as well as new N-heteroarylmethyl-m-phenylenediamine derivatives
10/02/2002CN1372557A Neurotrophin production/secretion promoting agent
10/02/2002CN1372554A Method for storing quaternary ammonium salt
10/02/2002CN1372548A Heterocyclic compounds and medicinal use thereof
10/02/2002CN1372543A new vitamin derivatives with cyclic substructures in the side chains, method and intermediates for their production and their use in the preparation of medicaments
1 ... 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 ... 337